Adam Gridley
-
Malvern-Based Ocugen Enters Merger Agreement with Company in Boston
Malvern-based Ocugen, a gene therapy and biopharmaceutical company that develops new treatments for rare and underserved eye diseases, has entered into a merger agreement with…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
